Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brent Sear
Institutions:
The University of Kansas Health System,
University of Kansas Medical Center
Observed institutions:
University of Kansas,
The University of Kansas Health System,
The University of Kansas Cancer Center,
University of Kansas Medical Center
ORCID:
0009-0008-3707-8297
Observed ORCID:
0009-0008-3707-8297
OpenAlex ID:
A5117723295
Results of a phase I study of alpelisib and sacituzumab govitecan (SG) in patients with HER2-negative metastatic breast cancer (MBC).
2025
·
Priyanka Sharma
, Jaimie Heldstab
, et al.
·
Journal of Clinical Oncology
·
4
PDF
E-cigarette puff topography instruction to enhance switching among COPD patients who smoke
2025
·
Eleanor L. S. Leavens
, Theodore L. Wagener
, et al.
·
Frontiers in Public Health
·
1
PDF
Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Assay for 4-Methylumbelliferone in Human Urine to determine the activity of Urinary β-Glucuronidase
2026
·
Brent Sear
, Paul Toren
, et al.
·
ChemRxiv
PDF
Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC)
2026
·
Anup Kasi
, Raed Moh’d Taiseer Al-Rajabi
, et al.
·
The Oncologist
Correction: E-cigarette puff topography instruction to enhance switching among COPD patients who smoke
2025
·
Eleanor L. S. Leavens
, Theodore L. Wagener
, et al.
·
Frontiers in Public Health
PDF
Show more works
View as search
Works count:
5
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type